Skip to main content
. 2021 Jan 7;12:100199. doi: 10.1016/j.bbih.2021.100199

Table 4.

Findings of D4R expression in LYM of patients with SCZ.

Reference Study n Sample Methodology Clinical features Findings
Ilani et al., 2004 Healthy controls 11 PBLs RT-PCR ND No differences in D4R mRNA
SCZ patients 14
Rodrigues et al., 2005 Healthy controls 45 PBLs Flow-cytometry BPRS No differences in D4R protein levels
SCZ patients 45 Significant inverse correlation (BPRS hebephrenic dimension score vs D4R)
Boneberg et al., 2006 Healthy controls 10 Leukocyte population
PBMCs
qRT-PCR ND Decreased D4R mRNA in T cells
SCZ patients 10
Kawano et al., 2011 Healthy controls 12 PBLs qRT-PCR PANSS, BACS-J, Treatment, Dose, Duration of illness No differences in D4R mRNA
SCZ patients 11 D4R mRNA positively correlated with working memory scales
Brito-Melo et al., 2012 Healthy controls
SCZ patients
20
40
LYM (CD4, CD8) Flow-cytometry CGIS, BPRS, PANSS, AIMS, Duration of illness and hospitalization,Dose of antipsychotic Increased percentages of CD4+D4R+ and CD8+D4R+ cells
AIMS inversely related to CD4+D4R+ ​cells
Ahmadian et al., 2014 Healthy controls 20 PBLs RT-PCR ND D4R expressed in all groups but no differences in mRNA
Drug-naïve SCZ patients 5
Drug-free SCZ patients (» 3 months) 15
Drug-medicated SCZ patients (» 3 years) 22
Fernandez-Egea et al., 2016 Healthy controls 18 LYM qRT-PCR BMI, Smoking, BACS, CGIS No differences in D4R mRNA
Chronic SCZ patients 18 D4R mRNA positively correlated with working memory scales

Abbreviations: Brief Psychiatric Rating Scale (BPRS), Positive and Negative Syndrome Scale (PANSS) for Schizophrenia, Brief Assessment of Cognition in Schizophrenia (BACS), Clinical Global Impression Scale (CGIS), Abnormal Involuntary Movement Scale (AIMS), Body mass index (BMI). No Data (ND).